XML 22 R6.htm IDEA: XBRL DOCUMENT v3.5.0.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Jul. 31, 2016
Jul. 31, 2015
Jul. 31, 2014
Cash flows from operating activities:      
Net income $ 608 $ 4,200 $ (790)
Adjustments to reconcile net income to net cash provided by operating activities:      
Impairment of long-lived assets 375 0 0
Impairment of goodwill 0 104 0
Impairment of Investment in ECSI 0 355 0
Depreciation and amortization 1,143 1,467 4,176
Deferred income tax benefit 1,697 1,154 (818)
Share based compensation expense 37 59 353
Tax impact of share-based compensation 0 (92) (32)
Loss (gain) on sale of assets and investment securities 135 (186) (13)
Net provision for (recovery of) contract adjustments and doubtful accounts (910) (413) 174
Net bad debt (recovery) expense 453 (326) 90
Decrease (increase) in:      
- contract receivables 7,394 (934) 1,855
- other current assets (400) (440) 192
- income tax receivable (329) 270 3,247
- other non-current assets 42 48 29
(Decrease) increase in:      
- accounts payable (3,157) 1,052 24
- accrued payroll costs (1,909) 1,805 630
- income taxes payable 40 132 (41)
- billings in excess of revenue 607 (1,909) (1,419)
- other accrued liabilities (29) 202 446
Net cash provided by operating activities 5,797 6,548 8,103
Cash flows from investing activities:      
Acquisition of noncontrolling interest of subsidiaries 0 (50) (689)
Proceeds from sale of subsidiary 150 0 0
Purchase of property, building and equipment (722) (735) (1,965)
Proceeds from sale of property, building and equipment 5 255 0
Proceeds from maturity of investments 26 0 0
Purchase of investment securities (154) (33) 53
Net cash used in investing activities (695) (563) (2,601)
Cash flows from financing activities:      
Dividends paid (2,066) (2,066) (2,054)
Proceeds from debt 6 384 544
Repayment of debt (547) (753) (710)
Net (repayments of) borrowings under lines of credit (380) (870) (4,956)
Distributions to noncontrolling interests (530) (537) (665)
Purchase of treasury stock 0 0 (173)
Net cash used in financing activities (3,517) (3,842) (8,014)
Effect of exchange rate changes on cash and cash equivalents (226) (329) (43)
Net increase (decrease) in cash and cash equivalents 1,359 1,814 (2,555)
Cash and cash equivalents at beginning of period 8,703 6,889 9,444
Cash and cash equivalents at end of period 10,062 8,703 6,889
Cash paid (received) during the period for:      
Interest 151 110 146
Income taxes 2,742 1,542 (2,303)
Supplemental disclosure of non-cash items:      
Dividends declared and not paid 861 1,033 1,033
Acquisition of noncontrolling interest of subsidiaries (loans receivable and stock) 0 233 1,073
Sale of subsidiary (loans receivable) 75 0 0
Proceeds from capital lease obligations $ 69 $ 322 $ 43